This Article is waiting for corrections.
Congressional Hearing On LDTs: Split On FDA Regulation But Support For VALID
Hyman, Phelps, & McNamara
Contributor
On March 21, 2024, the House Energy and Commerce held a subcommittee hearing titled "Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA's Proposed Rule."
